Marsh & McLennan Companies (NYSE:MRSH) Price Target Lowered to $203.00 at UBS Group

Marsh & McLennan Companies (NYSE:MRSHGet Free Report) had its price target dropped by UBS Group from $230.00 to $203.00 in a note issued to investors on Tuesday,Benzinga reports. The firm currently has a “buy” rating on the financial services provider’s stock. UBS Group’s price target would indicate a potential upside of 22.63% from the company’s current price.

Several other equities research analysts have also recently weighed in on MRSH. Citigroup upgraded Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 price objective for the company in a report on Wednesday, May 6th. Piper Sandler dropped their price objective on Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating for the company in a report on Tuesday, May 26th. Mizuho dropped their price objective on Marsh & McLennan Companies from $199.00 to $193.00 and set a “neutral” rating for the company in a report on Monday, April 13th. Weiss Ratings cut Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, May 11th. Finally, Raymond James Financial upgraded Marsh & McLennan Companies from an “outperform” rating to a “strong-buy” rating and set a $225.00 target price for the company in a research note on Tuesday, February 17th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Marsh & McLennan Companies has a consensus rating of “Hold” and an average target price of $200.19.

Check Out Our Latest Report on Marsh & McLennan Companies

Marsh & McLennan Companies Trading Up 1.9%

NYSE MRSH traded up $3.02 on Tuesday, hitting $165.54. The company’s stock had a trading volume of 435,716 shares, compared to its average volume of 3,017,447. Marsh & McLennan Companies has a 52-week low of $156.60 and a 52-week high of $222.57. The company has a debt-to-equity ratio of 1.28, a quick ratio of 1.11 and a current ratio of 1.11. The stock has a market cap of $79.97 billion, a P/E ratio of 20.65, a price-to-earnings-growth ratio of 2.41 and a beta of 0.62.

Marsh & McLennan Companies (NYSE:MRSHGet Free Report) last released its quarterly earnings data on Thursday, April 16th. The financial services provider reported $3.29 earnings per share for the quarter, topping the consensus estimate of $3.21 by $0.08. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.The business had revenue of $7.30 billion during the quarter. The company’s quarterly revenue was up 7.6% on a year-over-year basis. On average, analysts forecast that Marsh & McLennan Companies will post 10.38 earnings per share for the current year.

Insiders Place Their Bets

In related news, CEO John Q. Doyle sold 16,656 shares of Marsh & McLennan Companies stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the transaction, the chief executive officer directly owned 116,811 shares in the company, valued at approximately $18,889,506.81. The trade was a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.38% of the company’s stock.

Hedge Funds Weigh In On Marsh & McLennan Companies

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Numerai GP LLC lifted its holdings in Marsh & McLennan Companies by 966.2% during the third quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider’s stock worth $7,501,000 after buying an additional 33,729 shares during the period. Swiss Life Asset Management Ltd lifted its holdings in Marsh & McLennan Companies by 9.5% during the fourth quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider’s stock worth $24,960,000 after buying an additional 11,648 shares during the period. Rockland Trust Co. lifted its holdings in Marsh & McLennan Companies by 801.6% during the third quarter. Rockland Trust Co. now owns 12,073 shares of the financial services provider’s stock worth $2,433,000 after buying an additional 10,734 shares during the period. Barclays PLC lifted its holdings in Marsh & McLennan Companies by 41.7% during the third quarter. Barclays PLC now owns 2,202,372 shares of the financial services provider’s stock worth $443,844,000 after buying an additional 647,987 shares during the period. Finally, Sarasin & Partners LLP lifted its holdings in Marsh & McLennan Companies by 0.9% during the fourth quarter. Sarasin & Partners LLP now owns 934,732 shares of the financial services provider’s stock worth $173,411,000 after buying an additional 8,283 shares during the period. 87.99% of the stock is currently owned by hedge funds and other institutional investors.

Marsh & McLennan Companies Company Profile

(Get Free Report)

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.

Read More

Analyst Recommendations for Marsh & McLennan Companies (NYSE:MRSH)

Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.